Back to TARS
HUSSMAN STRATEGIC ADVISORS, INC. → TARS
HUSSMAN STRATEGIC ADVISORS, INC. TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$3.3M
Q3 2026
Peak value
$3.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.9M |
| Q4 2025 | $1.4M |
| Q1 2026 | $1.2M |
| Q2 2026 | $1.3M |
| Q3 2026 | $3.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.3M | 42.0K | — | — |
| Q2 2026 | $1.3M | 21.0K | — | — |
| Q1 2026 | $1.2M | 16.8K | — | — |
| Q4 2025 | $1.4M | 16.8K | — | — |
| Q3 2025 | $1.9M | 31.5K | — | — |
Other funds holding TARS
$155.5M
$126.3M
$105.9M
$101.3M